KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incyte (INCY) Cash & Equivalents (2016 - 2026)

Incyte filings provide 17 years of Cash & Equivalents readings, the most recent being $3.5 billion for Q1 2026.

  • For the quarter ending Q1 2026, Cash & Equivalents rose 78.25% year-over-year to $3.5 billion, compared with a TTM value of $3.5 billion through Mar 2026, up 78.25%, and an annual FY2025 reading of $3.1 billion, up 83.54% over the prior year.
  • Cash & Equivalents hit $3.5 billion in Q1 2026 for Incyte, up from $3.1 billion in the prior quarter.
  • The five-year high for Cash & Equivalents was $3.5 billion in Q1 2026, with the low at $987.3 million in Q2 2024.
  • Median Cash & Equivalents over the past 5 years was $2.7 billion (2022), compared with a mean of $2.5 billion.
  • The sharpest move saw Cash & Equivalents crashed 68.47% in 2024, then soared 98.01% in 2025.
  • Year by year, Cash & Equivalents stood at $3.0 billion in 2022, then grew by 8.88% to $3.2 billion in 2023, then plummeted by 47.47% to $1.7 billion in 2024, then skyrocketed by 83.54% to $3.1 billion in 2025, then rose by 11.73% to $3.5 billion in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $3.5 billion, $3.1 billion, and $2.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.